OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
85
Results
Show all
Save search
Copy query
Show results for
Unknown
(81)
Genomics
(3)
Metabolomics
(1)
Organisms
Homo sapiens
(3)
Repository
EGA
(3)
MetaboLights
(1)
Technology Type
Illumina HiSeq 2000
(1)
Mass spectrometry
(1)
Instrument Platform
Q Exactive
(1)
Publication Date
2024
(1)
CHEBI ID
CHEBI:133139
(1)
CHEBI:133141
(1)
CHEBI:133144
(1)
CHEBI:133469
(1)
CHEBI:133647
(1)
CHEBI:133649
(1)
CHEBI:133672
(1)
CHEBI:138368
(1)
CHEBI:14314
(1)
CHEBI:14336
(1)
CHEBI:15346
(1)
CHEBI:15350
(1)
CHEBI:15354
(1)
CHEBI:15356
(1)
CHEBI:15428
(1)
CHEBI:15676
(1)
CHEBI:15682
(1)
CHEBI:15694
(1)
CHEBI:15721
(1)
CHEBI:15727
(1)
CHEBI:15741
(1)
CHEBI:15846
(1)
CHEBI:15859
(1)
CHEBI:15891
(1)
CHEBI:15919
(1)
CHEBI:15927
(1)
CHEBI:16010
(1)
CHEBI:16040
(1)
CHEBI:16113
(1)
CHEBI:16235
(1)
Metabolite Name
1-(1-enyl-palmitoyl)-2-arachidonoyl-GPC (P-16:0/20:4)*
(1)
1-(1-enyl-palmitoyl)-2-arachidonoyl-GPE (P-16:0/20:4)*
(1)
1-(1-enyl-palmitoyl)-2-linoleoyl-GPE (P-16:0/18:2)*
(1)
1-(1-enyl-palmitoyl)-2-palmitoyl-GPC (P-16:0/16:0)*
(1)
1-(1-enyl-palmitoyl)-GPE (P-16:0)*
(1)
1-(1-enyl-stearoyl)-GPE (P-18:0)*
(1)
1-arachidonoyl-GPI (20:4)*
(1)
1-myristoyl-2-palmitoyl-GPC (14:0/16:0)
(1)
1-oleoyl-2-docosahexaenoyl-GPC (18:1/22:6)*
(1)
1-oleoyl-2-linoleoyl-GPC (18:1/18:2)*
(1)
1-oleoyl-2-linoleoyl-GPE (18:1/18:2)*
(1)
1-palmitoyl-2-arachidonoyl-GPE (16:0/20:4)*
(1)
1-palmitoyl-2-arachidonoyl-GPI (16:0/20:4)*
(1)
1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6)
(1)
1-palmitoyl-2-docosahexaenoyl-GPE (16:0/22:6)*
(1)
1-palmitoyl-2-oleoyl-GPC (16:0/18:1)
(1)
1-palmitoyl-2-stearoyl-GPC (16:0/18:0)
(1)
1-palmitoyl-GPC (16:0)
(1)
1-palmitoyl-GPE (16:0)
(1)
1-palmitoyl-GPI (16:0)
(1)
1-stearoyl-2-arachidonoyl-GPC (18:0/20:4)
(1)
1-stearoyl-2-arachidonoyl-GPE (18:0/20:4)
(1)
1-stearoyl-2-arachidonoyl-GPI (18:0/20:4)
(1)
1-stearoyl-2-docosahexaenoyl-GPC (18:0/22:6)
(1)
1-stearoyl-2-docosahexaenoyl-GPE (18:0/22:6)*
(1)
1-stearoyl-2-linoleoyl-GPC (18:0/18:2)*
(1)
1-stearoyl-2-oleoyl-GPC (18:0/18:1)
(1)
1-stearoyl-2-oleoyl-GPE (18:0/18:1)
(1)
2-hydroxyglutarate
(1)
2-oxoarginine*
(1)
Release Date
2025
(14)
2024
(11)
2023
(11)
2022
(11)
2019
(8)
2021
(7)
2017
(5)
2014
(4)
2018
(3)
2016
(2)
2013
(2)
2020
(1)
2015
(1)
2010
(1)
Previous
page
1 / 9
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
9
Next
page
Sort
by:
Relevance
Page size
10
A social-network behavioral health program on sustained long-term body weight and glycemic outcomes: 2-year follow-up of a 4-month Microclinic Health Program in Jordan.
Not available
S-EPMC6307340
|
biostudies-literature
Cite
Determinants of waterpipe smoking initiation among school children in Irbid, Jordan: a 4-year longitudinal analysis.
Not available
S-EPMC4138134
|
biostudies-literature
Cite
Physical activity promotion in daycare centres in Germany: study protocol for a cross-sectional survey within the BeweKi study.
Not available
S-EPMC10277102
|
biostudies-literature
Cite
[Symptoms of SARS-CoV-2 infections in children of day care age].
Not available
S-EPMC9645339
|
biostudies-literature
Cite
Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease.
Not available
S-EPMC6796530
|
biostudies-literature
Cite
SARS-CoV-2 seroconversion in children attending daycare versus adults in Germany between October 2020 and June 2021.
Not available
S-EPMC10504330
|
biostudies-literature
Cite
Molecular and microscopic analysis of the gut contents of abundant rove beetle species (Coleoptera, Staphylinidae) in the boreal balsam fir forest of Quebec, Canada.
Not available
S-EPMC3837482
|
biostudies-literature
Cite
Postoperative chemoradiotherapy and cetuximab for high-risk squamous cell carcinoma of the head and neck: Radiation Therapy Oncology Group RTOG-0234.
Not available
S-EPMC4121506
|
biostudies-literature
Cite
Impact and Influence of a Teaching Resident Rotation on Emergency Medicine Resident Physicians.
Not available
S-EPMC11957947
|
biostudies-literature
Cite
Phase I/II Trial of Labetuzumab Govitecan (Anti-CEACAM5/SN-38 Antibody-Drug Conjugate) in Patients With Refractory or Relapsing Metastatic Colorectal Cancer.
Not available
S-EPMC8259133
|
biostudies-literature
Cite
Previous
page
1 / 9
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
9
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets
